Expanding the Role of Pharmacists in the Administration of Long-Acting Injectable Antipsychotic Medications

Publication
Article
Pharmacy TimesJuly 2019 Gastrointestinal Issues
Volume 85
Issue 7

Continuing education for administration of long-acting injectable antipsychotic medications.

Faculty

Misty L. Gonzalez, PharmD, BCPP, Clinical Associate Professor, Southern Illinois University, Edwardsville School of Pharmacy, Edwardsville, Illinois

Danielle Moses, PharmD, BCPP, Psychiatric Pharmacist, SSM Health DePaul Hospital, St. Louis, Missouri

Educational Objectives

At the completion of this activity, the participant will be able to:

  • Examine nonadherence data among patients with mental illness
  • Identify legislative changes that have expanded the role of pharmacists in providing long-acting injectable antipsychotic (LAIA) medications to patients
  • Explore FDA-approved formulations and administration of LAIAs
  • Demonstrate the appropriate administration of LAI therapies in practice

Target Audience: Pharmacists

Activity Type: Application

Release Date: July 19, 2019

Expiration Date: July 19, 2020

Estimated Time to Complete Activity: 2.5 hours

Fee: This lesson is offered for free at www.pharmacytimes.org

Related Videos
Image credit: Chanintorn.v | stock.adobe.com - PTSD Mental health concept, Psychologist sitting and touch hand young depressed asian man for encouragement near window with low light environment.Selective focus-
Cropped view of senior man playing with puzzles on table- Image credit: LIGHTFIELD STUDIOS | stock.adobe.com
Image credit: SHUTTER DIN - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.